CCMP Capital is an American firm whose services focus on growth capital and leveraged buyout areas of equity investment. The firm employs many investment bankers to ensure quality service delivery to its clients. Its offices are in New York, Tokyo, London and Hong Kong. The New York office also serves as the company’s headquarter. As of 2007, Stephen Murray CCMP Capital on wsj was the 17th largest private equity fund worldwide. Since inception, the firm has invested over $12 billion in growth capital and leveraged buyout transactions.
Stephen Murray CCMP Capital was founded as Chemical Venture Partners by Chemical Bank in 1984. The firm was to serve as the venture capital and private equity arm of the bank. The first major growth of the firm was in 1996 when Chemical Bank acquired Chase Manhattan Bank. The acquisition provided the firm with an increased client base and new business territories. The firm adopted the name Chase Capital Partners.
In 2000, the group acquired JP Morgan & Co. The private equity firm had to change its name to JP Morgan Partners to reflect the acquisition. Other smaller firms that the group had acquired by that time were Robert Fleming & Co, Manufacturers Hanover, Hambrecht & Quist, and The Beacon Group.
When JP Morgan Chase acquired Bank One in 2004, JP Morgan Partners’ fate changed. The group decided to use Bank One’s One Equity Partners as its private equity investment arm. JP Morgan was faced with a tough choice. The firm decided to spinout of JP Morgan Chase.
The spinout was announced in March 2005, but was completed on July 31, 2006. As a part of the spinout, JP Morgan Chase sold its interest in the company to new investors. At the time of the spinout, JP Morgan Chase’s share in the private equity investment firm was valued at $925 million.
Stephen Murray is one of the JP Morgan Partners that worked hard to ensure successful spinout of the firm from JP Morgan Chase. He joined the firm in 1996 during the acquisition of Chase Manhattan. He became the President and the CEO of CCMP in 2007. He holds an economics degree from Boston College, and an MBA from Columbia Business School.
On July 31, 2006, CCMP Capital was born. The acronym represents all the former entities of the company. The firm did a fundraising just after the spinout, and managed to raise a staggering $3.4 billion from institutional investors. Apart from the fundraising, CCMP also sold Medpace in February 2014 for a staggering $900 million.
The company currently has investments in a number of companies such as Renovo, Smurfit Kappa group, Brake Bros Ltd, and Berry Plastics. It has continued to grow exponentially and has successfully established itself as an international private equity investment firm. This has been attributed to its quality services that ensure clients’ investments remain profitable.